Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


11-13 June 2019
Postillion Hotel Amsterdam,
Amsterdam, NL



Novel Approaches to Immunotherapies and Immuno-oncology

New and Refreshed for 2019!

New Half-Day Workshops
  • Morning - Bispecific Antibodies: New Strategies and Case Studies
  • Afternoon - Antibody-drug Conjugates (ADCs): New Strategies and Case Studies
Drug Development Focus
  • The 2019 program will have a strong “drug development” focus with more preclinical and clinical case studies and more sessions focused on moving drug programs from discovery through development and the lessons learned along the way
  • 2 Concurrent Tracks allowing you to customize your learning experience
Networking Opportunities!

Networking App - All registered attendees receive access to our conference networking app, which allows you to view the full attendee list and schedule meetings before you arrive in Amsterdam

Networking Cocktail Reception - Located inside the exhibit hall, attendees can enjoy cocktails while viewing scientific posters, live exhibitor demonstrations, and exchange business cards with fellow attendees. 

By the Numbers

Leading Academic and Industry Scientists
Innovative Presentations by World-Renowned Speakers
Poster Presentations to Discover New, Unpublished Methods and Data

Get Global Recognition of Your Work by Presenting a Poster

Benefits of presenting a poster:

1. FOCUSED DISCUSSIONS: Posters offer the opportunity to engage with others also interested in the same subject and application as yourself which could potentially lead to future collaboration.
2. RECEIVE IMPARTIAL CRITIQUES: An insightful, impartial discussion of your work by a peer can often provide ideas for improving your work downstream.
3. SHARPEN YOUR PRESENTATION SKILLS: Presenting a poster enables you to explain a concept in different ways to see which method is most well received and practice your visual and oral presentations.
4. HONE YOUR IDEAS: A poster is ideal for early stages of the research, when you may not have much more than an idea, and you stand to benefit a lot from discussing your idea with other researchers from the same field.

Deadline for poster submission is Friday, May 17, 2019

New for 2019! Student/Postdoc Poster Competition

Two student/postdoc winners will be selected to receive:

  1. Complimentary registration to attend the conference and pre-conference sessions
  2. Support for travel expenses (up to $400 for domestic or $800 for international flights, 2 nights at a hotel, ground transportation).

In order to be considered for this poster competition, you must be a student or postdoc member of The Antibody Society. If you are not already a member, you may register for a free student or postdoc membership here.  You must check the box on the poster submission form indicating that you want your abstract to be considered for the poster competition.

Deadline for competition submission: 24 April 24 2019
Winners will be notified by 1 May 2019

Please note, poster abstracts can still be submitted and accepted for presentation at the conference after 24 April, but any poster submissions received after 24 April will not be considered for the poster competition.

Join This List of Alumni from 2018

AB Studio Inc 


Ablynx NV 

Adaptimmune Ltd 

Aduro Biotech Europe 

Aelian Biotechnology 

AIMM Therapeutics 

Amgen Research Munich GmbH 

Amgen, Inc. 

Antikor Biopharma Ltd 

Aptevo Therapeutics 

Argen-X N.V. 


Boehringer Ingelheim 

Boehringer Ingelheim Pharmaceutical Inc. 

Celyad S.A. 


Christian-Albrechts-University Kiel 

ChromoTek GmbH 

CHRU Besancon/ITAC platform 


CureVac AG 

Elasmogen Ltd 

EPO Berlin-Buch GmbH (EPO) 



ETH Zurich 

ETH Zurich/Swiss Federal Institute of Te 

Experimental Biotherapeutics Centre

FairJourney Biologics 

Garvan Institute of Medical Research 

Genentech, Inc. 

Genmab BV 

Ghent University 

Gilead Sciences 

Ginkgo Bioworks 

Goshen College 

Gustave Roussy Cancer Centre  

Institute of Molecular & Cell Biology 


Kagoshima University 

Karolinska Institutet 

Kookmin University 

Kyowa Hakko 



Leiden University 

Leiden University Medical Center 



Nestle Skin Health 

Nestle Skin Health/Galderma RandD 

Novimmune SA 


Prothix B.V. 

Radboud Institute for Molecular Life Sci 

Ragon Institute of MGH, MIT and Harvard 

Roche Innovation Center Zurich


Sanofi Aventis R & D 

Shemyakin and Ovchinnikov Institute of B 


Symphogen AS 

Tagworks Pharmaceuticals 

Taipei Medical University 

Takis Srl 

The Harley Street Clinic 

The Netherlands Cancer Institute 

TheraPharm Deutschland GmbH 

Tohoku University 

TU-Braunschweig, Dep. Biotechnology 

UCB UCb Celltech 

UCL Cancer Institute 


Utrecht University College London 

University Hospital of Erlangen 

University Medical Center Hamburg-Eppend 

University of Cologne 

University of Oxford 

University of Southampton 

University of Zurich 

Uppsala University 

Utrecht University 

WuXi Biologics 

Y-mAbs Therapeutics, Inc. 


Zymeworks Inc

Become an Event Sponsor or Exhibitor

Showcase your products and services to antibody scientists and executives. To request a floor plan, or to see a list of available package options, please contact Kristin Skahan at or +1-857-504-6730.

About The Antibody Society

The Antibody Society is an international, non-profit representing individuals and organizations involved in antibody-related research and development. The Society has a variety of initiatives and working groups focused on improving the antibody field.

We are:

- Creating opportunities for education and networking;

- Monitoring and reporting advances in the commercial pipeline for antibody and CAR-T therapeutics;

- Creating standards for characterizing antibody and T-cell receptor repertoires, and engaging this field;

- Engaging government and international agencies on matters concerning the antibody community;

 Please join us!